News

Within a few years, these last spent fuel rods can then be safely transported off-site for storage, reprocessing and the manufacturing of fresh reactor fuel. That’s projected to be 2026 for Unit ...
In 2020, Daiichi Sankyo and AZ agreed to carry out a clinical trial exploring the combination of Tagrisso with patritumab deruxtecan in patients with this form of cancer who have specific EGFR ...
Although with e.g. Fukushima Daiichi’s triple meltdown the zircalloy fuel rods were partially destroyed, it was the formation of hydrogen gas inside the reactor vessels and the hydrogen ...
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...
Merck & Co Inc. (MRK) and Daiichi Sankyo on Thursday said that the companies have withdrawn their application to the U.S. Food and Drug Administration (FDA) seeking permission to commercialize ...
The IDeate-Esophageal01 study is set to evaluate Merck & Daiichi's ADC drug ifinatamab deruxtecan in pre-treated patients with esophageal squamous cell carcinoma.
The damaged nuclear reactors at Japan's Fukushima Daiichi nuclear power plant, which was crippled by a March 11, 2011 tusnami. ... Parts of the control-rod drive mechanism, ...
Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a competitive field. Hiroyuki Okuzawa is working to keep it that way.
Daiichi and AZ’s aim of improving the broader public’s understanding of life with breast cancer was also the impetus for the choice to debut the ad during Thursday Night Football, which last ...
Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effe ...
Daiichi Sankyo is in trouble with the U.K.’s Prescription Medicines Code of Practice Authority (PMCPA) yet again. But, while the firm was found to have brought discredit upon the industry, it ...